НовостиBenzingaLeerink Partners Initiates Coverage On Palvella Therapeutics with Outperform Rating, Announces Price Target of $228 Leerink Partners Initiates Coverage On Palvella Therapeutics with Outperform Rating, Announces Price Target of $228 Benzinga 2026.11.16 13:30 (GMT+0) Открыть на Benzinga Другие новости